Advances in Pharmacoepidemiology and Drug Safety

Nada Suvajdžić-Vuković

Publications

• Case Report
  Challenge of Using Antiplatelet Drugs in Patients with Primary Immune Thrombocytopenia and Recently Implanted Coronary Stents-Splenectomy as a Therapeutic Option
  Author(s): Dragomir Marisavljevic, Olivera Markovic, Marija Zdravković, Saša Hinić, Nada Suvajdžić-Vuković and Branka FilipovićDragomir Marisavljevic, Olivera Markovic, Marija Zdravković, Saša Hinić, Nada Suvajdžić-Vuković and Branka Filipović
  
  Background: Immune thrombocytopenic purpura (ITP) in the patients with implanted coronary stents is related with serious risks of haemorrhage related to dual antiplatelet therapy on the one hand and stent thrombosis if antiplatelet therapy is interrupted on the other hand. Therefore, the main objective in these patients is the correction of thrombocytopenia and continuous use of antiplatelet drugs. Case report: We present the patient with implanted stents after acute myocardial infarction (AMI) and severe ITP who was successfully treated with splenectomy. After the patient experienced AMI, primary percutaneous coronary intervention (PCI) with implantation of stents has been performed. Thrombocytopenia (21 × 109/L) was registered for the first time after PCI intervention when it has been noticed a massive hematoma of whole right arm at .. View More»
  DOI: 10.4172/2167-1052.1000220

  Abstract PDF